Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > What is next?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Nov 21, 2024 9:00am
41 Views
Post# 36323432

RE:RE:RE:RE:What is next?

RE:RE:RE:RE:What is next?We need a leader to represent our interests. I vote for GranhamB the vulture no shares Ventripoint or @LyleWood & team Fud. He can be the #1 Loser!MDR
GranhamB ( You really got it in for Ventripoint. The only conclusion I can make of your disdain for it is that you must have dropped a bundle on it years back and it's your mission to see it fail. :) always with your (factsrule ) to analyze the past and denigrate Ventripoint the vulture. I saw live here this connect and disconnect SlipperyjAMS one of your many fake live accounts come to give you a thumbs up :-) your manipulator's agenda Fud and their many fake accounts mec negative #vpt,
GranhamB the vulture good for Ventripoint see = positif
Bravo Dr. Adams the visionary for this thecnology, The BEST automation and analysis of the PLANET GEN3EHO On the Ascend website https://ascendcv.com/ I think they know more about the Ventripoint tech than the whiners on this board.I also think that Dr. Adams the visionary with Ventripoint will silence the denigrators with FDA V4.0.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities